Search Resources (English): Drug controls

Examines the question of harmonisation of pharmaceutical regulation and its implications for women and public health. Urges that safety standards be paramount and the particular needs of women and other groups are not lost.

Examines the Canadian system of adverse drug reactions reporting and that women’s particular susceptibilities to drug-related health risks must be taken into consideration.

Presents the results of a survey where Canadians were asked to give their views and opinions on the effectiveness of Health Canada's methods to communicate health product safety information.

Aims to provide the media, policy-makers, non-governmental organizations and other concerned groups with an introduction to the issues surrounding the international agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and public health.

Presents the detailed analysis and rational, as well as recommendations, that led to the forum's priorities, outlined in Volume I.

Discusses the origins of confidentiality in drug regulation, the scope of regulations, the development and consequence of excessive secrecy in drug regulation, the benefits of openness of drug information, and the need for transparency at the international level.

Outlines concerns about direct-to-consumer advertising, including lack of public regulation and targeting of already healthy populations.